Evidence map›Paper›PMID 33065115›Full record

ArticleThe Journal of pediatrics2021

Discriminating Multisystem Inflammatory Syndrome in Children Requiring Treatment from Common Febrile Conditions in Outpatient Settings.

Rebecca F Carlin, Avital M Fischer, Zachary Pitkowsky, Dori Abel, Taylor B Sewell, Erika Grun Landau, Steve Caddle, Laura Robbins-Milne, Alexis Boneparth, Josh D Milner and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Oral manifestations of multisystemic inflammatory syndrome in children (MIS-C) and Kawasaki disease associated to COVID-19: A systematic review.Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry · 2022
    Pooled it
  3. Guideline
  4. Article
  5. Response to "The importance of an early gastroenteritis diagnosis to discard MIS-C during SARS-CoV-2 pandemic".Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children.Infectious disease clinics of North America · 2022
    Review
  12. Review
  13. Article
  14. Pharmacological treatment of COVID-19: an opinion paper.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Review
  15. COVID-19 in Children.Infectious disease clinics of North America · 2022
    Review
  16. Article
  17. Article
  18. Multisystem inflammatory syndrome in childrenTurkish journal of medical sciences · 2021
    Review
  19. Review
  20. Multisystem inflammatory syndrome in children with COVID-19.The American journal of emergency medicine · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Rebecca F CarlinDivision of Pediatric Critical Care and Hospital Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Avital M FischerDivision of Pediatric Critical Care and Hospital Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Zachary PitkowskyColumbia University Vagelos College of Physicians and Surgeons, New York, NY.
Dori AbelNewYork-Presbyterian Hospital, New York, NY.
Taylor B SewellDivision of Pediatric Critical Care and Hospital Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Erika Grun LandauDepartment of Pediatrics, Columbia University Irving Medical Center, New York, NY.
Steve CaddleDivision of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Laura Robbins-MilneDivision of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Alexis BoneparthDivision of Pediatric Allergy, Immunology and Rheumatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Josh D MilnerDivision of Pediatric Allergy, Immunology and Rheumatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Eva W CheungDivision of Pediatric Critical Care and Hospital Medicine, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Philip ZachariahDivision of Pediatric Infectious Disease, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Melissa S StockwellDivision of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY; Department of Population and Family Health, Mailman School of Public Health, Columbia University, New York, NY.
Brett R AndersonDivision of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY.
Mark GorelikDivision of Pediatric Allergy, Immunology and Rheumatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; NewYork-Presbyterian Hospital, New York, NY. Electronic address: mg4082@cumc.columbia.edu.
Columbia University Irving Medical Center · USNew York Hospital Queens · USColumbia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine whether patients with multisystem inflammatory syndrome in children (MIS-C) demonstrated well-defined clinical features distinct from other febrile outpatients, given the difficulties of seeing acute care visits during the severe acute respiratory syndrome coronavirus 2 pandemic and the risks associated with both over- and underdiagnosis of MIS-C. STUDY

designThis case-controlled study compared patients diagnosed with and treated for MIS-C at a large urban children's hospital with patients evaluated for fever at outpatient acute care visits during the peak period of MIS-C. Symptomatology and available objective data were extracted. Comparisons were performed using t tests with corrections for multiple comparisons, and multivariable logistic regression to obtain ORs.

resultsWe identified 44 patients with MIS-C between April 16 and June 10, 2020. During the same period, 181 pediatric patients were evaluated for febrile illnesses in participating outpatient clinics. Patients with MIS-C reported greater median maximum reported temperature height (40°C vs 38.9, P < .0001), and increased frequency of abdominal pain (OR 12.5, 95% CI [1.65-33.24]), neck pain (536.5, [2.23-129,029]), conjunctivitis (31.3, [4.6-212.8]), oral mucosal irritation (11.8, [1.4-99.4]), extremity swelling or rash (99.9, [5-1960]), and generalized rash (7.42, [1.6-33.2]). Patients with MIS-C demonstrated lower absolute lymphocyte (P < .0001) and platelet counts (P < .05) and greater C-reactive protein concentrations (P < .001).

conclusionsPatients treated for MIS-C due to concern for potential cardiac injury show combinations of features distinct from other febrile patients seen in outpatient clinics during the same period.

Indexed as

Ambulatory CareAdolescentAge FactorsChildChild, PreschoolCOVID-19Diagnosis, DifferentialFemaleFeverHumansMaleRetrospective StudiesSymptom AssessmentSystemic Inflammatory Response SyndromeKawasaki diseasemultisystem inflammatory syndrome in childrenmyocarditisSARS-CoV-2

Identifiers

PMID33065115
PMCPMC7553071
OpenAlexW3093017592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.